These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24907231)

  • 1. Serum FGF21 levels in adult m.3243A>G carriers: clinical implications.
    Koene S; de Laat P; van Tienoven DH; Vriens D; Brandt AM; Sweep FC; Rodenburg RJ; Donders AR; Janssen MC; Smeitink JA
    Neurology; 2014 Jul; 83(2):125-33. PubMed ID: 24907231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-patient variability of heteroplasmy levels in urinary epithelial cells in carriers of the m.3243A>G mutation.
    de Laat P; Rodenburg RJ; Smeitink JAM; Janssen MCH
    Mol Genet Genomic Med; 2019 Feb; 7(2):e00523. PubMed ID: 30516030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGF21 in ataxia patients with spinocerebellar atrophy and mitochondrial disease.
    Su SL; Wang WF; Wu SL; Wu HM; Chang JC; Huang CS; Cheng WL; Soong BW; Lee YC; Li JY; Kuo SJ; Chen M; Huang CN; Liu CS
    Clin Chim Acta; 2012 Dec; 414():225-7. PubMed ID: 23031666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obstetric complications in carriers of the m.3243A>G mutation, a retrospective cohort study on maternal and fetal outcome.
    de Laat P; Fleuren LH; Bekker MN; Smeitink JA; Janssen MC
    Mitochondrion; 2015 Nov; 25():98-103. PubMed ID: 26455484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial DNA mutation m.3243A>G is associated with altered mitochondrial function in peripheral blood mononuclear cells, with heteroplasmy levels and with clinical phenotypes.
    Geng X; Zhang Y; Yan J; Chu C; Gao F; Jiang Z; Zhang X; Chen Y; Wei X; Feng Y; Lu H; Wang C; Zeng F; Jia W
    Diabet Med; 2019 Jun; 36(6):776-783. PubMed ID: 30536471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of 3243A>G mutation in mtDNA presenting as apparently idiopathic hyperCKemia.
    Rubegni A; Cardaioli E; Chini E; Da Pozzo P; Battisti C; Malandrini A; Federico A
    J Neurol Sci; 2014 Mar; 338(1-2):232-4. PubMed ID: 24468540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of myopathic findings in 50 patients with the 3243A>G mutation in mitochondrial DNA.
    Kärppä M; Herva R; Moslemi AR; Oldfors A; Kakko S; Majamaa K
    Brain; 2005 Aug; 128(Pt 8):1861-9. PubMed ID: 15857931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor 21: a novel biomarker for human muscle-manifesting mitochondrial disorders.
    Suomalainen A
    Expert Opin Med Diagn; 2013 Jul; 7(4):313-7. PubMed ID: 23782039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors.
    Chow WS; Xu A; Woo YC; Tso AW; Cheung SC; Fong CH; Tse HF; Chau MT; Cheung BM; Lam KS
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2454-9. PubMed ID: 23887638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, segregation, and phenotype of the mitochondrial DNA 3243A>G mutation in children.
    Uusimaa J; Moilanen JS; Vainionpää L; Tapanainen P; Lindholm P; Nuutinen M; Löppönen T; Mäki-Torkko E; Rantala H; Majamaa K
    Ann Neurol; 2007 Sep; 62(3):278-87. PubMed ID: 17823937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fear of disease progression in carriers of the m.3243A > G mutation.
    Custers JAE; de Laat P; Koene S; Smeitink J; Janssen MCH; Verhaak C
    Orphanet J Rare Dis; 2018 Nov; 13(1):203. PubMed ID: 30424784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful Glycemic Control Decreases the Elevated Serum FGF21 Level without Affecting Normal Serum GDF15 Levels in a Patient with Mitochondrial Diabetes.
    Murakami T; Ueba Y; Shinoto Y; Koga Y; Kaneda D; Hatoko T; Kato T; Yonemitsu S; Muro S; Oki S
    Tohoku J Exp Med; 2016 Jun; 239(2):89-94. PubMed ID: 27212224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders.
    Lehtonen JM; Forsström S; Bottani E; Viscomi C; Baris OR; Isoniemi H; Höckerstedt K; Österlund P; Hurme M; Jylhävä J; Leppä S; Markkula R; Heliö T; Mombelli G; Uusimaa J; Laaksonen R; Laaksovirta H; Auranen M; Zeviani M; Smeitink J; Wiesner RJ; Nakada K; Isohanni P; Suomalainen A
    Neurology; 2016 Nov; 87(22):2290-2299. PubMed ID: 27794108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fibroblast growth factor 21 concentration in children with mitochondrial disease does not depend on the disease stage, but rather on the disease genotype.
    Wesół-Kucharska D; Rokicki D; Greczan M; Kaczor M; Czekuć-Kryśkiewicz E; Piekutowska-Abramczuk D; Halat-Wolska P; Ciara E; Jaworski M; Jezela-Stanek A
    Pediatr Endocrinol Diabetes Metab; 2022; 28(2):141-151. PubMed ID: 35620925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life, fatigue and mental health in patients with the m.3243A > G mutation and its correlates with genetic characteristics and disease manifestation.
    Verhaak C; de Laat P; Koene S; Tibosch M; Rodenburg R; de Groot I; Knoop H; Janssen M; Smeitink J
    Orphanet J Rare Dis; 2016 Mar; 11():25. PubMed ID: 26988355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: a 3-year prospective study in China.
    Li H; Dong K; Fang Q; Hou X; Zhou M; Bao Y; Xiang K; Xu A; Jia W
    J Hepatol; 2013 Mar; 58(3):557-63. PubMed ID: 23142063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mitochondrial DNA heteroplasmy of the m.3243A>G mutation in maternally inherited diabetes and deafness].
    Cataldo LR; Olmos P; Valerie Smalley S; Díez A; Parada A; Gejman R; Fadic R; Santos JL
    Rev Med Chil; 2013 Mar; 141(3):305-12. PubMed ID: 23900320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum FGF21 and RBP4 levels in patients with chronic hepatitis C.
    Kukla M; Berdowska A; Stygar D; Gabriel A; Mazur W; Łogiewa-Bazger B; Sobala-Szczygieł B; Bułdak RJ; Rokitka M; Zajęcki W; Kępa L; Sawczyn T; Zwirska-Korczala K
    Scand J Gastroenterol; 2012 Sep; 47(8-9):1037-47. PubMed ID: 22670657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride.
    Li H; Fang Q; Gao F; Fan J; Zhou J; Wang X; Zhang H; Pan X; Bao Y; Xiang K; Xu A; Jia W
    J Hepatol; 2010 Nov; 53(5):934-40. PubMed ID: 20675007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease.
    Grady JP; Pickett SJ; Ng YS; Alston CL; Blakely EL; Hardy SA; Feeney CL; Bright AA; Schaefer AM; Gorman GS; McNally RJ; Taylor RW; Turnbull DM; McFarland R
    EMBO Mol Med; 2018 Jun; 10(6):. PubMed ID: 29735722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.